Pioneering diagnostics

bioMérieux Italia | Pioneering diagnostics

ULTIME NOTIZIE

19.03.2019

Baxter and bioMérieux announce collaboration to improve identification and treatment of acute kidney injury
27.02.2019

bioMérieux – 2018 Financial Results
07.02.2019

bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing
13.11.2018

bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with FDA clearance and CE Marking
09.11.2018

bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market

NOTIZIE

Catalogo Formazioni

CATALOGO CORSI DI FORMAZIONE SCIENTIFICI, TECNICI E MANAGERIALI 2019/2020

Creiamo valore per i nostri clienti

Scopri attraverso I video, il valore dei clienti per bioMérieux

FilmArray

APPROFONDIMENTI

bioMérieux Corporate | bioMérieux Industry | bioMérieux Diagnostics

bioMérieux Italia Spa | Sede Legale Via di Campigliano, 58 Loc.Ponte a Ema

50012 Bagno a Ripoli (FI) Italia | Capitale Sociale € 9.000.000 i.v. Socio Unico

n.REA FI 443558 | C.F. 07146020586 | P.IVA 01696821006